NR4A1 and breast carcinoma: A prior study utilizing the older version of the NPCR and SEER incidence database presented temporal changes in the incidence rate of hormone receptor (HR) (referred as ER and PR) positive and negative breast cancer in women aged 20 years or older during 2004–2016.